Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spiros Hiotis

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|January 10, 2006
Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II studyElliot Newman, Milan Potmesil, Theresa Ryan, et al.
Journal of Surgical Oncology|June 7, 2022
Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgeryRebekah C Macfie, Da Eun Cha, Elizabeth Gleeson, et al.
Annals of Surgical Oncology|November 22, 2023
Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal OriginElad Sarfaty, Nazanin Khajoueinejad, Allen T Yu, et al.
Annals of Surgical Oncology|May 20, 2023
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal AdenocarcinomaRebekah Macfie, Yael Berger, Hongdau Liu, et al.
Gastroenterology|June 16, 2009
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinomaSasan Roayaie, Iris N Blume, Swan N Thung, et al.
Annals of Surgical Oncology|December 11, 2013
Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched studyMichael S Leapman, Ghalib Jibara, Parissa Tabrizian, et al.
World Journal of Surgery|April 4, 2023
Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by ResectionDa Eun Cha, Allen T Yu, Nazanin Khajoueinejad, et al.
Annals of Surgical Oncology|July 13, 2024
Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor OutcomesAllen T Yu, David N Hanna, Thomas M Li, et al.
Annals of Surgical Oncology|October 14, 2025
Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver MetastasesJudy Li, Giacomo Waller, Yunyun Qin, et al.
Annals of Surgical Oncology|July 20, 2011
Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinomaDeirdre J Cohen, Elliot Newman, Syma Iqbal, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|January 10, 2006
Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II studyElliot Newman, Milan Potmesil, Theresa Ryan, et al.
Journal of Surgical Oncology|June 7, 2022
Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgeryRebekah C Macfie, Da Eun Cha, Elizabeth Gleeson, et al.
Annals of Surgical Oncology|November 22, 2023
Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal OriginElad Sarfaty, Nazanin Khajoueinejad, Allen T Yu, et al.
Annals of Surgical Oncology|May 20, 2023
Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal AdenocarcinomaRebekah Macfie, Yael Berger, Hongdau Liu, et al.
Gastroenterology|June 16, 2009
A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinomaSasan Roayaie, Iris N Blume, Swan N Thung, et al.
Annals of Surgical Oncology|December 11, 2013
Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched studyMichael S Leapman, Ghalib Jibara, Parissa Tabrizian, et al.
World Journal of Surgery|April 4, 2023
Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by ResectionDa Eun Cha, Allen T Yu, Nazanin Khajoueinejad, et al.
Annals of Surgical Oncology|July 13, 2024
Genetic Clustering of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Patients of Colorectal Origin: KRAS and Not TP53 Cluster Alterations are Associated with Poor OutcomesAllen T Yu, David N Hanna, Thomas M Li, et al.
Annals of Surgical Oncology|October 14, 2025
Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver MetastasesJudy Li, Giacomo Waller, Yunyun Qin, et al.
Annals of Surgical Oncology|July 20, 2011
Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinomaDeirdre J Cohen, Elliot Newman, Syma Iqbal, et al.
Pageof 3